AVTX
Avalo Therapeutics, Inc.
+0.14 (+0.84%)16.72USD210K成交股數897M市值–本益比(近四季)15198.2股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | 0.00 | – | – | 249K+6% | 0.00-100% | 0.00 | 570K | 236K | 643K |
| 營業成本 | – | – | – | – | 0.00 | – | −714K | 343K | −80K | −222K | 247K | 708K |
| 毛利 | – | – | – | – | – | – | 963K-8855% | −343K+428% | 80K | 792K | −11K | −65K |
| 毛利率 | – | – | – | – | – | – | 386.7% | – | – | 138.9% | -4.7% | -10.1% |
| 研發費用 | 23.4M | 14.0M | 13.3M | 13.6M | 14.1M | 9.1M | 9.5M | 4.6M | 2.1M | 1.9M | 1.2M | 4.7M |
| 銷售管理費用 | 8.1M | 6.9M | 6.5M | 5.6M | 5.2M | 5.5M | 4.3M | 4.5M | 3.2M | 2.7M | 2.5M | 2.4M |
| 營業利益 | −31.5M+63% | −20.9M+42% | −19.7M+54% | −19.2M+101% | −19.3M-41% | −14.7M+92% | −12.9M+243% | −9.6M+34% | −32.8M | −7.7M | −3.8M | −7.2M |
| 營業利益率 | – | – | – | – | – | – | -5,165.1% | – | – | -1,343.7% | -1,589.0% | -1,112.0% |
| 稅後淨利 | −36.4M+75% | −19.6M+49% | −13.7M-160% | −30.6M-131% | −20.8M-83% | −13.1M+61% | 23.0M-541% | 98.5M-1302% | −121M | −8.2M | −5.2M | −8.2M |
| 淨利率 | – | – | – | – | – | – | 9,251.8% | – | – | -1,433.0% | -2,215.3% | -1,274.2% |
| 稀釋 EPS | -0.83-57% | -0.98-22% | -0.48-83% | -2.19-84% | -1.92-99% | -1.25-100% | -2.83-89% | -14.07-90% | -141.14 | 257.98 | -26.83 | -140.73 |
| 稀釋股數 | 43.6M | 20.1M | 13.4M | 14.0M | 10.8M | 10.5M | 10.8M | 7.7M | 859K | 278K | 195K | 58.2K |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 85.4M | 25.0M | 15.9M | 27.0M | 42.3M | 125M | 81.9M | 93.4M | 110M | 7.4M | 10.2M | 6.3M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | 38K |
| 存貨 | – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 18K |
| 總資產 | 491M | 99.9M | 116M | 125M | 127M | 139M | 98.5M | 108M | 124M | 21.0M | 29.3M | 24.2M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 42.1M | 31.6M | 33.4M | 33.6M | 22.0M | 15.9M | 75.7M | 110M | 225M | 13.7M | 14.6M | 31.2M |
| 股東權益 | 449M | 68.3M | 83.0M | 91.5M | 105M | 123M | 21.1M | −13.6M | −113M | 7.3M | 14.7M | −7.0M |
| 負債比 | 8.6% | 31.6% | 28.7% | 26.8% | 17.4% | 11.5% | 76.9% | 102.0% | 181.7% | 65.2% | 49.8% | 128.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −17.7M+87% | – | – | – | −9.5M | – | – | −6.2M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | 0.00 | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | −6.2M | – | – | – |
| 折舊攤銷 | – | 17K | – | – | – | 135K | – | – | 34K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 59K
| 產品 | 59K | 100.0% | -86.6% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 59K | -86.6% | −78.3M | -132,642.4% | -5.84 | – |
| FY2024 | 441K | -77.1% | −35.1M | -7,965.8% | -20.91 | −49.1M |
| FY2023 | 1.9M | -89.3% | −31.5M | -1,639.5% | -113.58 | −30.8M |
| FY2022 | 18.1M | +234.4% | −41.7M | -230.8% | -1063.00 | −26.8M |
| FY2021 | 5.4M | -19.4% | −84.4M | -1,563.1% | – | −71.0M |
| FY2020 | 6.7M | -0.8% | −63.5M | -947.9% | – | −40.6M |
| FY2019 | 6.8M | -4.0% | −16.1M | -238.1% | – | −19.4M |
| FY2018 | 7.0M | – | −40.1M | -569.9% | -1.20 | −3.7M |